Our mission is to find safer, smarter and more effective treatments for children with cancer.

Welcome to Kate Amato Foundation

Cancer is the leading cause of death by disease in children. For those who survive, the side effects of treatment can cause severe long-term health problems. To honor Kate’s life, and continue the fight for other children, Kate Amato Foundation is dedicated to finding safer, smarter and more effective treatments for children with cancer. Our vision is to fund innovative pediatric cancer research that accelerates the pace of progress and saves young lives.



Help Kate Amato Foundation fund Pediatric Cancer Research. 



Start a fundraising event for Kate Amato Foundation click here.



Volunteer your time and talents at one of our fundraising events.

Did You Know?

more than
children receive treatment for cancer each year
cancer treatments have been specifically developed and approved for children in the last 20 years
1 out of
children with cancer will not survive

Recently Funded

Understanding the Role of MYCN-Driven FA Update to LIPID Metabolism and Tumor Growth to Identify a Targeted Approach for High-Risk MYCN-Amplified Neuroblastoma

Ling Tao, PhD

Texas Children’s Cancer Center, Baylor College of Medicine


High-Risk MYCN-Amplified Neuroblastoma
Elucidating the Role of Invariant Natural Killer T Cells in Neuroblastoma Antitumor Immunity

Hamid Bassiri, MD

University of Pennsylvania and Children’s Hospital of Philadelphia (CHOP)


High-risk Neuroblastoma
Transcriptional Addiction in Acute Myeloid Leukemia

Max Pimkin, MD, PhD

Dana Farber Cancer Institute, Boston Children’s Hospital, Harvard Medical School


MLL-Rearranged Acute Myeloid Leukemia (AML)